Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1987 Oct;33:2349–2354.

Current Treatment of Psoriasis

J David Epstein
PMCID: PMC2218552  PMID: 21263959

Abstract

Psoriasis is a relatively common chronic dermatosis that is genetically determined and environmentally influenced. Because it is ideopathic, therapy is presently supportive, directed at optimal control, patient understanding, and prevention of recurrence. Because this multifactorial condition may involve skin and nails, musculoskeletal system, and psyche in various combinations and degrees, an organized co-operative team approach involving the patient, the family, and appropriately experienced health-care providers is most beneficial. Many topical and systemic medications, as well as physical therapeutic modalities, both established and innovative, are available for use sequentially or in various combinations to suite the individual and his/her particular psoriasis. This brief review will outline the better established dermatologic therapeutic principles and options currently available for this patient group.

Keywords: dermatology, psoriasis, therapy

Full text

PDF
2349

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abel E. A., DiCicco L. M., Orenberg E. K., Fraki J. E., Farber E. M. Drugs in exacerbation of psoriasis. J Am Acad Dermatol. 1986 Nov;15(5 Pt 1):1007–1022. doi: 10.1016/s0190-9622(86)70265-x. [DOI] [PubMed] [Google Scholar]
  2. Baker B. S., Griffiths C. E., Lambert S., Powles A. V., Leonard J. N., Valdimarsson H., Fry L. The effects of cyclosporin A on T lymphocyte and dendritic cell sub-populations in psoriasis. Br J Dermatol. 1987 Apr;116(4):503–510. doi: 10.1111/j.1365-2133.1987.tb05869.x. [DOI] [PubMed] [Google Scholar]
  3. Bickers D. R. Position paper--PUVA therapy. American Academy of Dermatology. J Am Acad Dermatol. 1983 Feb;8(2):265–270. doi: 10.1016/s0190-9622(83)70032-0. [DOI] [PubMed] [Google Scholar]
  4. Current status of oral PUVA therapy for psoriasis. Eye protection revisions. J Am Acad Dermatol. 1982 May;6(5):851–855. doi: 10.1016/s0190-9622(82)70074-x. [DOI] [PubMed] [Google Scholar]
  5. Current status of oral PUVA therapy for psoriasis. J Am Acad Dermatol. 1979 Aug;1(2):106–117. doi: 10.1016/s0190-9622(79)80030-4. [DOI] [PubMed] [Google Scholar]
  6. Davies M. G., Briffa D. V., Greaves M. W. Systemic toxicity from topically applied salicylic acid. Br Med J. 1979 Mar 10;1(6164):661–661. doi: 10.1136/bmj.1.6164.661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Duvic M., Goldberg G., Prawer S. E., Brenn P., Hefter H. S. Climatotherapy of psoriasis at the Dead Sea. J Am Acad Dermatol. 1986 Dec;15(6):1298–1301. doi: 10.1016/s0190-9622(86)80046-9. [DOI] [PubMed] [Google Scholar]
  8. Ellis C. N., Voorhees J. J. Etretinate therapy. J Am Acad Dermatol. 1987 Feb;16(2 Pt 1):267–291. [PubMed] [Google Scholar]
  9. FARBER E. M., ROTH R. J., ASCHHEIM E., EDDY D. D., EPINETTE W. W. ROLE OF TRAUMA IN ISOMORPHIC RESPONSE IN PSORIASIS. Arch Dermatol. 1965 Mar;91:246–251. doi: 10.1001/archderm.1965.01600090054011. [DOI] [PubMed] [Google Scholar]
  10. Farber E. M., Abel E. A., Charuworn A. Recent advances in the treatment of psoriasis. J Am Acad Dermatol. 1983 Mar;8(3):311–321. doi: 10.1016/s0190-9622(83)70033-2. [DOI] [PubMed] [Google Scholar]
  11. Farber E. M., Pearlman D., Abel E. A. An appraisal of current systemic chemotherapy for psoriasis. Arch Dermatol. 1976 Nov 29;112(Spec No):1679–1688. doi: 10.1001/archderm.1976.01630360047013. [DOI] [PubMed] [Google Scholar]
  12. Griffiths C. E., Powles A. V., Leonard J. N., Fry L., Baker B. S., Valdimarsson H. Clearance of psoriasis with low dose cyclosporin. Br Med J (Clin Res Ed) 1986 Sep 20;293(6549):731–732. doi: 10.1136/bmj.293.6549.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. INGRAM J. T. The approach to psoriasis. Br Med J. 1953 Sep 12;2(4836):591–594. doi: 10.1136/bmj.2.4836.591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Katz H. I., Hien N. T., Prawer S. E., Mastbaum L. I., Mooney J. J., Samson C. R. Superpotent topical steroid treatment of psoriasis vulgaris--clinical efficacy and adrenal function. J Am Acad Dermatol. 1987 Apr;16(4):804–811. doi: 10.1016/s0190-9622(87)70105-4. [DOI] [PubMed] [Google Scholar]
  15. Kligman A. M., Frosch P. J. Steroid addiction. Int J Dermatol. 1979 Jan-Feb;18(1):23–31. doi: 10.1111/j.1365-4362.1979.tb01905.x. [DOI] [PubMed] [Google Scholar]
  16. Le Vine M. J., White H. A., Parrish J. A. Components of the Goeckerman regimen. J Invest Dermatol. 1979 Aug;73(2):170–173. doi: 10.1111/1523-1747.ep12581626. [DOI] [PubMed] [Google Scholar]
  17. Olsen E. A., Cornell R. C. Topical clobetasol-17-propionate: review of its clinical efficacy and safety. J Am Acad Dermatol. 1986 Aug;15(2 Pt 1):246–255. doi: 10.1016/s0190-9622(86)70164-3. [DOI] [PubMed] [Google Scholar]
  18. Pittelkow M. R., Perry H. O., Muller S. A., Maughan W. Z., O'Brien P. C. Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study. Arch Dermatol. 1981 Aug;117(8):465–468. [PubMed] [Google Scholar]
  19. Roenigk H. H., Jr, Auerbach R., Maibach H. I., Weinstein G. D. Methotrexate guidelines--revised. J Am Acad Dermatol. 1982 Feb;6(2):145–155. doi: 10.1016/s0190-9622(82)80064-9. [DOI] [PubMed] [Google Scholar]
  20. Runne U., Kunze J. Short-duration ('minutes') therapy with dithranol for psoriasis: a new out-patient regimen. Br J Dermatol. 1982 Feb;106(2):135–139. doi: 10.1111/j.1365-2133.1982.tb00922.x. [DOI] [PubMed] [Google Scholar]
  21. Seville R. H. Psoriasis and stress. II. Br J Dermatol. 1978 Feb;98(2):151–153. doi: 10.1111/j.1365-2133.1978.tb01616.x. [DOI] [PubMed] [Google Scholar]
  22. Seville R. H. Psoriasis and stress. Br J Dermatol. 1977 Sep;97(3):297–302. doi: 10.1111/j.1365-2133.1977.tb15186.x. [DOI] [PubMed] [Google Scholar]
  23. Shore R. N. Treatment of psoriasis with prolonged application of tape. J Am Acad Dermatol. 1986 Sep;15(3):540–542. doi: 10.1016/s0190-9622(86)80506-0. [DOI] [PubMed] [Google Scholar]
  24. Stern R. S., Thibodeau L. A., Kleinerman R. A., Parrish J. A., Fitzpatrick T. B. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med. 1979 Apr 12;300(15):809–813. doi: 10.1056/NEJM197904123001501. [DOI] [PubMed] [Google Scholar]
  25. Stern R., Zierler S., Parrish J. A. Psoriasis and the risk of cancer. J Invest Dermatol. 1982 Feb;78(2):147–149. doi: 10.1111/1523-1747.ep12506290. [DOI] [PubMed] [Google Scholar]
  26. Van Joost T., Heule F., Stolz E., Beukers R. Short-term use of cyclosporin A in severe psoriasis. Br J Dermatol. 1986 May;114(5):615–620. doi: 10.1111/j.1365-2133.1986.tb04070.x. [DOI] [PubMed] [Google Scholar]
  27. WHYTE H. J., BAUGHMAN R. D. ACUTE GUTTATE PSORIASIS AND STREPTOCOCCAL INFECTION. Arch Dermatol. 1964 Mar;89:350–356. doi: 10.1001/archderm.1964.01590270036008. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES